Log in
  • A3P Biomedical logo Svenska
  • A3P Biomedical logo English
A3P Biomedical logo
  • About Us
    About Us
    • Vision and mission
      Business model
    • Strategy and goals
      History
    • Sustainability
      Code of Conduct
      Whistleblowing Policy
    • The Board
      Scientific Advisory Board
      Management
      Annual General Meeting 2023
      General Meetings archive
    • Work with us
  • Stockholm3
    Stockholm3
    • Publications
  • Media
    Media
    • Press Releases
    • A3P in media
    • Subscribe
    • Image Archive
  • Contact
    Contact
    • Partners
    • Take Stockholm3
  • A3P Biomedical logo Svenska
  • A3P Biomedical logo English
  • About us
    • Vision and mission
    • Business model
    • Strategy and goals
    • History
    • Sustainability
      • Code of Conduct
      • Whistleblowing Policy
    • The Board
    • Scientific Advisory Board
    • Management
    • Annual General Meeting 2023
      • General Meetings archive
    • Work with us
  • Stockholm3
    • Publications
  • Media
    • Press Releases
    • A3P in media
    • Subscribe
    • Image Archive
  • Contact
    • Partners
    • Take Stockholm3
Take Stockholm3

Press releases & Media

Press releases

  • Groves Medical Group starts offering Stockholm3 in the UK
    February 1, 2023
  • Clinical study validates that Stockholm3 provides significantly higher clinical benefit than European prostate cancer risk calculator
    January 12, 2023
  • A3P Biomedical appoints Andreas Hoel as new VP of Marketing & Sales
    November 1, 2022
More press releases

A3P in media

  • Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
    May 6, 2022
  • Finally time for public screening of prostate cancer? (In Swedish)
    November 22, 2021
  • Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
    October 6, 2021
More articles

Contact

David Rosén
David Rosén
Chief Executive Officer
+46 10 1823325
[email protected]
  • Media
    • Press Releases
    • A3P in media
    • Subscribe
    • Image Archive
About us
Stockholm3
Media
Contact

A3P Biomedical AB (publ), Address: Kungsgatan 24, SE 111 35 Stockholm, Sweden
E-mail: [email protected]
Phone: +46 10 1823300

A3P in Social Media

  • Cookies
  • Privacy Policy

Subscribe